Organon (OGN) Cash & Equivalents (2020 - 2026)
Organon (OGN) reported Cash & Equivalents of $1.13 billion for Q2 2026, up 89.0% from $599 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
Organon (OGN) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Organon posted Cash & Equivalents of $574 million, down 15.0% from FY2024.
- Cash & Equivalents has declined for four consecutive years, though with a five-year compound annual growth rate of 116.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $675 million in FY2024 (-2.6%), $693 million in FY2023 (-1.8%), $706 million in FY2022 (-4.2%) and $737 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to Q4 2020.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with growth averaging 28.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 392.2%); the low point was Q3 2022 (a decline of 50.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.12 billion (Q1 2026), $574 million (Q4 2025) and $672 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Organon | 3.60 Bn | 109.00 Mn | 847.00 Mn | 1.13 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 574.00 Mn |
| Sep 30, 2025 | 672.00 Mn |
| Jun 30, 2025 | 599.00 Mn |
| Mar 31, 2025 | 547.00 Mn |
| Dec 31, 2024 | 675.00 Mn |
| Sep 30, 2024 | 763.00 Mn |
| Jun 30, 2024 | 704.00 Mn |
| Mar 31, 2024 | 575.00 Mn |
| Dec 31, 2023 | 693.00 Mn |
| Sep 30, 2023 | 414.00 Mn |
| Jun 30, 2023 | 326.00 Mn |
| Mar 31, 2023 | 459.00 Mn |
| Dec 31, 2022 | 706.00 Mn |
| Sep 30, 2022 | 499.00 Mn |
| Jun 30, 2022 | 545.00 Mn |
| Mar 31, 2022 | 694.00 Mn |
| Dec 31, 2021 | 737.00 Mn |
| Sep 30, 2021 | 1.01 Bn |
API Access
Organon Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();